Phase II trial of RXI 109 for treatment of keloids
Phase of Trial: Phase II
Latest Information Update: 25 Mar 2015
At a glance
- Drugs RXI 109 (Primary)
- Indications Keloids
- Focus Therapeutic Use
- Sponsors RXi Pharmaceuticals
- 25 Mar 2015 New trial record
- 23 Mar 2015 According to RXi Pharmaceuticals media release, this trial is expected to begin in near future.
- 15 Feb 2015 Trial design presented at the 73rd Annual Meeting of the American Academy of Dermatology.